Showing results (1921-1930 of 2,009) with videos related to

Sort By:
Pageof 201
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 10, 2018
Genetics of Human Longevity From Incomplete Data: New Findings From the Long Life Family StudyAnatoliy I Yashin, Konstantin G Arbeev, Deqing Wu, et al.
Cancer|March 5, 2020
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastomaHamed Akbari, Saima Rathore, Spyridon Bakas, et al.
Journal of Neurointerventional Surgery|October 18, 2023
Intraoperative angiography in neurosurgery: temporal trend, access site, and operative indication considerations from a 6-year institutional experienceThilan Tudor, Jonathan Sussman, Georgios S Sioutas, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 31, 2019
Maternal Interleukin-6 Is Associated With Macaque Offspring Amygdala Development and BehaviorJulian S B Ramirez, Alice M Graham, Jacqueline R Thompson, et al.
JCO Precision Oncology|September 4, 2025
Next-Generation Sequencing of Intraoperatively Acquired Cerebrospinal Fluid and Matched Tumor Tissue in Patients Undergoing Surgical Resection for GlioblastomaErica L Carpenter, Jacob E Till, Dominique Ballinger, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Life Sciences|January 1, 1996
Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonistD L Williams, K L Murphy, N A Nolan, et al.
Journal of Medicinal Chemistry|November 26, 2014
Decreasing the rate of metabolic ketone reduction in the discovery of a clinical acetyl-CoA carboxylase inhibitor for the treatment of diabetesDavid A Griffith, Daniel W Kung, William P Esler, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2017
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancerStephen J Bagley, Shawn Kothari, Charu Aggarwal, et al.
Cancer|January 29, 2019
A phase 2 study of glembatumumab vedotin, an antibody-drug conjugate targeting glycoprotein NMB, in patients with advanced melanomaPatrick A Ott, Anna C Pavlick, Douglas B Johnson, et al.
Pageof 201